Smad expression in human atherosclerotic lesions: Evidence for impaired TGF-β/Smad signaling in smooth muscle cells of fibrofatty lesions

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 24, Issue 8, 2004, Pages 1391-1396

  Kalinina, Natalia ^a,b   Agrotis, Alex ^a   Antropova, Yulia ^b   Ilyinskaya, Olga ^b   Smirnov, Vladimir ^b   Tararak, Eduard ^b   Bobik, Alex ^a  

^a ALFRED HOSPITAL   (Australia)

^b INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

Collage; Human atherosclerotic lesions; p15INK4B; p21Waf1; Smad

Indexed keywords

PROTEIN P15; PROTEIN P21; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; AORTA ATHEROSCLEROSIS; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROTECTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MONOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN VARIANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; UPREGULATION;

ADULT; AGED; AORTA, THORACIC; AORTIC DISEASES; ARTERIOSCLEROSIS; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DEATH, SUDDEN; DNA-BINDING PROTEINS; FEMALE; FIBROSIS; HUMANS; LIPIDS; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RNA SPLICING; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEINS;

EID: 3943049366     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000133605.89421.79     Document Type: Article

References (39)

1. Massague J, Balin SW, Lo RS. TGFβ signaling in growth control, cancer and heritable disorders. Cell. 2000;103:295-309.
2. Bobik A, Agrotis A, Kanellakis P, Dilley R, Krushinsky A, Smirnov V, Tararak E, Condron M, Kostolias G. Distinct patterns of transforming growth factor-β isoform and receptor expression in human atherosclerotic lesions. Circ. 1999;99:2883-2891.
3. Lutgens E, Daemen MJAP. Transforming growth factor-β. A local or systemic mediator of plaque stability? Circ Res. 2001;89:853-855.
4. Mallat Z, Gojova A, Marchiol-Fournigault C, Esposito B, Kamate C, Merval R, Fradelizi D, Tedgui A. Inhibition of transforming growth factor-β signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res. 2001;89:930-934.
5. Lutgens E, Gijbels M, Smook M, Heeringa P, Gotwals P, Koteliansky VE, Daemen MJAP. Transforming growth factor-β mediates balance between inflammation and fibrosis during plaque progression. Arterioscler Thromb Vasc Biol. 2002;22:975-982.
6. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A. 1993;90:770,
7. Shah AH, Tabayoyong WB, Kimm SY, Kim S-J, Parijs Lv, Lee C. Reconstitution of lethally irradiated adult mice with dominant negative mutant TGF-β Type II receptor-transduced bone marrow leads to myeloid expansion and inflammatory disease. J Immunol. 2002;169:3485-3491.
8. Gorelik L, Flavell RA. Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity. 2000;12:171-181.
9. Verrecchia F, Chu M-L, Mauviel A. Identification of novel TGF-β/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/ promoter transactivation approach. J Biol Chem. 2001;276:17058-17062.
10. Verrecchia F, Mauviel A. Transforming growth factor-β signaling through the smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol. 2002;118:211-215.
11. Holmes A, Abraham DJ, Sa S, Shiwen X, Black CM, Leask A. CTGF and SMADs, maintenance of scleroderma phenotype is independent of smad signaling. J Biol Chem. 2001;276:10594-10601.
12. Yuan W, Varga J. Transforming growth factor-β repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3. J Biol Chem. 2001;276:38502-38510.
13. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier J-M. Direct binding of smad3 and smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 1998;17:3091-3100.
14. Lupu F, Bergonzelli GE, Heim DA, Cousin E, Genton CY, Bachmann F, Kruithof EK. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arterioscler Thromb. 1993;13:1090-1100.
15. Chen W-B, Lenshow W, Tiede K, Fischer JW, Kalhoff H, Ungefroren H. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-β in pancreatic tumor cells. J Biol Chem. 2002; 277:36118-36128.
16. O'Brien KD, Olin KL, Alpers CE, Chiu W, Hudkins K, Wight TN, Chait A. Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: co-localization of biglycan with apolipoproteins. Circ. 1998;98:519-527.
17. Ink4B transcription in response to TGF-β. EMBO J. 2000;19:5178-5193.
18. Waf1/Cip1 regulation by transforming growth factor-β. J Biol Chem. 2000;275: 29244-29256.
19. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr., Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, Am Heart Association. Arterioscler Thromb Vasc Biol. 1995;15(9):1512-31.
20. Kalinina N, Agrotis A, Tararak E, Antropova Y, Kanellakis P, Ilyinskaya O, Quinn MT, Smirnov V, Bobik A. Cytochrome b558-dependent NAD(P)H oxidase-phox units in smooth muscle and macrophages of atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2002;22: 2037-2043.
21. Ward MR, Kanellakis P, Ramsey D, Funder J, Bobik A. Eplerenone suppresses constrictive remodeling and collagen accumulation after angioplasty in porcine coronary arteries. Circ. 2001;104:467-472.
22. Yagi K, Goto D, Hamamoto T, Takenoshita S, Kato M, Miyazono K. Alternatively spliced variant of Smad2 lacking exon3. Comparison with wild-type smad2 and Smad3. J Biol Chem. 1999;274:703-709.
23. Pierreux CE, Nicolas FJ, Hill CS. Transforming growth factor beta-independent shuttling of Smad4 between the cytoplasm and nucleus. Mol Cell Biol. 2000;20:9041-9054.
24. Robson CN, Gnanapragasam V, Byrne RL, Collins AT, Neal DE. Transforming growth factor-β1 up-regulates p15, p21 and p27 and blocks cell cycling in human prostate epithelium. J Endocrinol. 1999;160:257-266.
25. Ducos K, Panterne B, Fortunel N, Hatzfeld A, Monier MN, Hartfeld J. p21(cip1) mRNA is controlled by endogenous transforming growth factor-β1 in quiescent human hematopoietic stem/progenitor cells. J Cell Physiol. 2000;184:80-85.
26. Seoane J, Pouponnot C, Staller P, Schader M, Eilers M, Massague J. TGFβ influences myc, miz-1 and smad to control the CDK inhibitor p15INK4b. Nat Cell Biol. 2001;3:400-408.
27. Cip1/SDI-1/WAF-1 gene is involved in chondrogenic differentiation of ATDC5 cells in vitro. J Biol Chem. 2001;276:33249-33256.
28. Ink4b gene during megakaryocytic differentiation of normal and myelodysplastic hematopoietic progenitors. Blood. 2001;98:495-497.
29. Cip1/Waf1 in monocytic differentiation. EMBO J. 1999;18:1223-1234.
30. Lawrence R, Hartmann DJ, Sonenshein GE. Transforming growth factor β 1 stimulates type V collagen expression in bovine vascular smooth muscle cells. J Biol Chem. 1994;269:9603-9609.
31. Funaba M, Zimmerman CM, Mathews LS. Modulation of smad2-mediated signaling by extracellular signal-regulated kinase. J Biol Chem. 2002;277:41361-41368.
32. Engel ME, McDonnell MA, Law BK, Moses HL. Interdependence of SMAD and JNK signaling in transforming growth factor-β-mediated transcription. J Biol Chem. 1999;274:37413-37420.
33. Ashcroft GS, Yang X, Glicks AB, Weinstein M, Letterio JJ, Mizel DE, Anzano M, Greenwell-Wild T, Wahl SM, Deng C, Roberts AB. Mice lacking smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol. 1999;1:260-266.
34. Evans RA, Tian YC, Steadman R, Phillips AO. TGF-β1-mediated fibroblast-myofibroblast terminal differentiation-The role of Smad proteins. Exp Cell Res. 2003;282:90-100.
35. Kitamura Y, Ninomiya H. Smad expression of hepatic stellate cells in liver cirrhosis in vivo and hepatic stellate cell line in vitro. Pathol Int. 2003;53:18-26.
36. Hobson KG, Cho K, Adamson LK, Greenhalgh DG. Burn-induced thymic apoptosis corresponds with altered TGF-β1 and Smad2/3. J Surg Res. 2002;105:4-9.
37. Xu J, Oakley J, McGee EA. Stage-specific expression of Smad2 and Smad3 during folliculogenesis. Biol Reprod. 2002;66:1571-1578.
38. Andreeva ER, Pugach IM, Orekhov AN. Collagen-synthesising cells in initial and advanced atherosclerotic lesions of human aorta. Atherosclerosis. 1997;130:133-142.
39. Herman MP, Sukhova GK, Libby P, Gerdes N, Tang N, Horton DB, Kilbride M, Breitbart RE, Chun M, Schonbeck U. Expression of neutrophil collagenase (matrix metalloproetinase-8) in human atheroma. Circ. 2001;104:1899-1904.